ingredients within Kirin Holdings' Health Science group. Building on over 75 years of fermentation innovation and Kirin's 100+ year legacy of fermentation excellence, Kyowa delivers premium, science-backed branded ingredients to the nutraceutical,...
promising formulations into scalable commercial realities. “As the pharmaceutical industry accelerates innovation, from GLP-1 therapies to complex biologics, the pressure to deliver manufacturing reliability, consistent supply, and robust...
Drug Administration (FDA) granted Breakthrough Device status to XT-ViVo® and TimeSeal® for human kidney preservation up to 120 hours for transplant. For more information please visit, www.x-therma.com
versus placebo by 24 weeks. Overall, patients treated with this dose of IMAAVY showed a mean Hgb improvement of at least 1g/dL as early as Week 1.1,c To be presented at the European Hematology Association (EHA) 2026 Congress, these results mark an...
VERTANICAL announced that Exilby® (VER-01) has received marketing authorization in Germany for the treatment of chronic low back pain with a radicular (neuropathic) component. The authorization marks a major milestone for VERTANICAL and highlights...
to moderate Alzheimer’s disease who were receiving ZUNVEYL. The BEACON study evaluated provider-reported outcomes from 21 investigators treating 162 long-term care patients with mild to moderate Alzheimer’s disease who received ZUNVEYL for 3 to 12...
global market value of more than $5 billion and are dispensed across primary care, pediatric, and hospital settings in over 100 countries. Because these products are already in the field across more than 100 countries, their packaging is actively...
TelyRx Holdings Inc. a technology-enabled healthcare and online pharmacy platform focused on expanding access to FDA-approved medications across the United States, today announced it has surpassed one million prescriptions filled nationwide since...
have been dermatologist supervised tested for safety and sensitivity. Clinical testing of the 3 step facial regimen showed 100% of participants reported their skin looked and felt smoother and 97% felt their skin looked younger. Additionally, the...
Brain Navi Biotechnology announced that its KrystoLens, the single-use neuro-endoscope, has officially received certification from the Taiwan Food and Drug Administration (TFDA), marking an important milestone in the company's development in...
SK bioscience announced that it has been designated as a supplier of influenza vaccines for UNICEF's 2026 immunization programs and has begun shipments for countries in the Southern Hemisphere. Beginning in September, the company will also...
Niagen in clinical studies exploring IV and injectable administration. Currently, the program supports more than 175 ongoing and developing research studies. In addition, the Company recently initiated the Niagen Bioscience Trainee Grant Program,...
Medella Springs, a wellness brand focused on nature-inspired supplements and whole-body support, is helping families navigate the growing conversation around focus, attention, and daily cognitive wellness with AddiVance, a drug-free, non-stimulant...
pathogens in a single test. A core feature of Seegene's syndromic real-time PCR technology is its ability to detect up to 14 pathogens that cause similar signs and symptoms in a single tube while providing quantitative information to support more...
more confidently in their daily routine, while building on the trusted performance associated with the CONTOUR® brand.” 1 CONTOUR COMFORT pen needles have been developed to support ease of use in daily therapy. They combine advanced 5-bevel tip...
Administration (FDA) has approved XOCOVA® (ensitrelvir), an oral antiviral, for post-exposure prophylaxis (PEP) of COVID‑19 in adults and adolescents 12 years of age and older following contact with an individual who has COVID-19.3 This approval...
in combination with doxorubicin, vinblastine and dacarbazine (AVD) for the treatment of adult and adolescent patients 12 years of age and older with previously untreated Stage III or IV classical Hodgkin Lymphoma (cHL). This approval marks a...
mutated and non-BRCA HRR gene-mutated mCRPC. Prostate cancer is the second most common cancer in men, with approximately 1 in 8 diagnosed during their lifetime.2 mCRPC occurs when prostate cancer grows and spreads to other parts of the body despite...
program has generated valuable insights into ALS disease biology, including pharmacogenomic response associated with the UNC13A genotype, biomarker data collected at seven longitudinal time points, and a comprehensive analysis of the "Floor Effect"...
product (LBP) indicated in the United States to prevent recurrent Clostridioides difficile infection (rCDI) in individuals 18 years of age and older following antibacterial treatment for rCDI. Under the agreement, the parties will work jointly to...